Silo Pharma announces 1-for-15 reverse stock split effective June 2, 2026

Silo Pharma, Inc.

1-for-15 reverse split effective 4:01 pm ET on June 2, 2026; post-split trading begins June 3 under same symbol SILO.
Outstanding shares reduced from ~16.267M to ~1.084M; authorized shares cut proportionately to 6,666,667.
CUSIP changes to 82711P 300; fractional shares rounded up to the next whole share.
Equitable adjustments made to equity awards and warrants, including exercise prices.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.